Cargando…
Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression
Despite the advent of many therapeutic agents, such as bortezomib and lenalidomide that have significantly improved the overall survival, multiple myeloma remains an incurable disease. Failure to cure is multifactorial and can be attributed to the underlying genetic heterogeneity of the cancer and t...
Autores principales: | Mondello, Patrizia, Cuzzocrea, Salvatore, Navarra, Michele, Mian, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386771/ https://www.ncbi.nlm.nih.gov/pubmed/28099912 http://dx.doi.org/10.18632/oncotarget.14610 |
Ejemplares similares
-
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunity
por: Mondello, Patrizia, et al.
Publicado: (2015) -
ALCAM-EGFR interaction regulates myelomagenesis
por: Luo, Hongmei, et al.
Publicado: (2021) -
Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014) -
MAF functions as a pioneer transcription factor that initiates and sustains myelomagenesis
por: Katsarou, Alexia, et al.
Publicado: (2023) -
The cellular immune system in myelomagenesis: NK cells and T cells in the development of MM and their uses in immunotherapies
por: Dosani, T, et al.
Publicado: (2015)